Bifidobacterium infantis 35624
Also known as: B. infantis 35624, Bifantis, Align probiotic, Bifidobacterium longum subsp. infantis 35624
Overview
Most-studied probiotic strain for IBS. Repeated RCTs show symptom improvement at 1 billion CFU/day.
Frequently Asked About Bifidobacterium infantis 35624
How much Bifidobacterium infantis 35624 should I take?
When is the best time to take Bifidobacterium infantis 35624?
Should I take Bifidobacterium infantis 35624 with food?
Does Bifidobacterium infantis 35624 interact with medications?
What does Bifidobacterium infantis 35624 pair well with?
Who should not take Bifidobacterium infantis 35624?
What are the side effects of Bifidobacterium infantis 35624?
Dosage
Trials show benefit emerging over 4 weeks; safe for long-term use
Generally safe in pregnancy and pediatrics; consult provider in immunocompromised states
Research & Studies
We haven’t curated landmark studies for Bifidobacterium infantis 35624yet — one-click into the primary literature here. PubMed (RCTs) is usually the highest-signal starting point.
Mechanism of Action
- • Modulates intestinal cytokine balance (raises IL-10, lowers IL-6/TNF-alpha)
- • Restores gut barrier function in inflammatory states
- • Influences enteric nervous system signaling
Evidence Quality
Multiple RCTs in IBS show reduced abdominal pain, bloating, and urgency. Effect is strain-specific — generic B. infantis products may not deliver the same benefit.
Safety & Contraindications
- • Avoid in severely immunocompromised patients due to rare bacteremia risk with any probiotic
- • Central venous catheters in critically ill patients
- • Transient gas or bloating in the first 1-2 weeks
Considered safe
No concerns
Interactions
- • Separate from antibiotics by 2+ hours
- • Synergistic with prebiotics (inulin, GOS) but not required
- • No specific concerns
Stacking & Synergies
Buying Guide
- • Strain ID printed on label
- • Guaranteed CFU through expiration
- • Cold-chain handling for refrigerated forms
- • Strain matters — generic B. infantis is not equivalent
- • Allow 4 weeks before judging effect
- • Most IBS RCT data is for IBS-D and mixed-type
Related Guides
In-depth guides covering Bifidobacterium infantis 35624 — protocols, comparisons, and use cases.
More in Probiotic
Other ingredients in the Probiotic category.
Cite this page
Formulate Research Team. (2026, June). Bifidobacterium infantis 35624 — Evidence-Based Supplement Guide. Formulate Supplement Encyclopedia. https://app.formulate-health.app/learning/supplements/bifidobacterium-infantis-35624
Educational content based on published research and our scoring methodology. Not medical advice — consult a qualified healthcare provider before starting, stopping, or changing supplements, especially if you take medications, are pregnant, or have a medical condition.